{"entity":{"type":"insider","cik":"0002005384","url":"/insider/0002005384","json_url":"/insider/0002005384.json","name":"Forbion IV Management B.V.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":9,"first":"2024-11-15","last":"2025-01-02","span_basis":"filed_date"},"name_variants":[{"name":"Forbion IV Management B.V.","source":"filing","n_filings":9,"first_seen":"2024-11-15","last_seen":"2025-01-02"}],"transactions":[{"id":4871824,"accession":"0000950170-25-000445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-000445","line_url":"/filing/0000950170-25-000445#line-1","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29846.0,"shares_display":"29,846","price_per_share":25.5369,"price_display":"25.54","price_state":"stated","total_value":762174.3174,"total_display":"762,174.32","total_whole":"762,174","shares_owned_after":10656172.0,"shares_owned_after_display":"10,656,172","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-30","filed_date":"2025-01-02","scope":"insider"},{"id":2774420,"accession":"0000950170-24-141146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-141146","line_url":"/filing/0000950170-24-141146#line-2","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41472.0,"shares_display":"41,472","price_per_share":25.9522,"price_display":"25.95","price_state":"stated","total_value":1076289.6384,"total_display":"1,076,289.64","total_whole":"1,076,290","shares_owned_after":10686018.0,"shares_owned_after_display":"10,686,018","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-27","filed_date":"2024-12-30","scope":"insider"},{"id":2774413,"accession":"0000950170-24-141146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-141146","line_url":"/filing/0000950170-24-141146#line-1","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33438.0,"shares_display":"33,438","price_per_share":26.0072,"price_display":"26.01","price_state":"stated","total_value":869628.7536,"total_display":"869,628.75","total_whole":"869,629","shares_owned_after":10727490.0,"shares_owned_after_display":"10,727,490","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-26","filed_date":"2024-12-30","scope":"insider"},{"id":2750056,"accession":"0000950170-24-140408","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-140408","line_url":"/filing/0000950170-24-140408#line-4","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16164.0,"shares_display":"16,164","price_per_share":25.6639,"price_display":"25.66","price_state":"stated","total_value":414831.2796,"total_display":"414,831.28","total_whole":"414,831","shares_owned_after":10760928.0,"shares_owned_after_display":"10,760,928","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-24","filed_date":"2024-12-26","scope":"insider"},{"id":2750049,"accession":"0000950170-24-140408","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-140408","line_url":"/filing/0000950170-24-140408#line-3","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25132.0,"shares_display":"25,132","price_per_share":25.4904,"price_display":"25.49","price_state":"stated","total_value":640624.7328,"total_display":"640,624.73","total_whole":"640,625","shares_owned_after":10777092.0,"shares_owned_after_display":"10,777,092","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-26","scope":"insider"},{"id":2750043,"accession":"0000950170-24-140408","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-140408","line_url":"/filing/0000950170-24-140408","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49772.0,"shares_display":"49,772","price_per_share":25.598006833159207,"price_display":"25.60","price_state":"stated","total_value":1274063.9961,"total_display":"1,274,064.00","total_whole":"1,274,064","shares_owned_after":10807853.0,"shares_owned_after_display":"10,807,853","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-20","filed_date":"2024-12-26","scope":"insider","n_lines":2},{"id":2834265,"accession":"0000950170-24-139069","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-139069","line_url":"/filing/0000950170-24-139069#line-3","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56506.0,"shares_display":"56,506","price_per_share":25.4452,"price_display":"25.45","price_state":"stated","total_value":1437806.4712,"total_display":"1,437,806.47","total_whole":"1,437,806","shares_owned_after":10851996.0,"shares_owned_after_display":"10,851,996","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-19","filed_date":"2024-12-20","scope":"insider"},{"id":2834259,"accession":"0000950170-24-139069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-139069","line_url":"/filing/0000950170-24-139069","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100728.0,"shares_display":"100,728","price_per_share":26.099072011754426,"price_display":"26.10","price_state":"stated","total_value":2628907.3256,"total_display":"2,628,907.33","total_whole":"2,628,907","shares_owned_after":10954712.0,"shares_owned_after_display":"10,954,712","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-20","scope":"insider","n_lines":2},{"id":3228735,"accession":"0000950170-24-137893","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-137893","line_url":"/filing/0000950170-24-137893","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114384.0,"shares_display":"114,384","price_per_share":25.95429437683592,"price_display":"25.95","price_state":"stated","total_value":2968756.008,"total_display":"2,968,756.01","total_whole":"2,968,756","shares_owned_after":11056966.0,"shares_owned_after_display":"11,056,966","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-18","scope":"insider","n_lines":2},{"id":3228725,"accession":"0000950170-24-137893","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-137893","line_url":"/filing/0000950170-24-137893#line-1","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1096.0,"shares_display":"1,096","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":27400.0,"total_display":"27,400.00","total_whole":"27,400","shares_owned_after":11123614.0,"shares_owned_after_display":"11,123,614","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-18","scope":"insider"},{"id":3036437,"accession":"0000950170-24-136642","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-136642","line_url":"/filing/0000950170-24-136642#line-3","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25751.0,"shares_display":"25,751","price_per_share":25.0106,"price_display":"25.01","price_state":"stated","total_value":644047.9606,"total_display":"644,047.96","total_whole":"644,048","shares_owned_after":11124710.0,"shares_owned_after_display":"11,124,710","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-13","filed_date":"2024-12-16","scope":"insider"},{"id":3036435,"accession":"0000950170-24-136642","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-136642","line_url":"/filing/0000950170-24-136642","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166011.0,"shares_display":"166,011","price_per_share":25.394867068447272,"price_display":"25.39","price_state":"stated","total_value":4215827.2769,"total_display":"4,215,827.28","total_whole":"4,215,827","shares_owned_after":11176424.0,"shares_owned_after_display":"11,176,424","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-12","filed_date":"2024-12-16","scope":"insider","n_lines":2},{"id":3228621,"accession":"0000950170-24-135796","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-135796","line_url":"/filing/0000950170-24-135796","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":154038.0,"shares_display":"154,038","price_per_share":25.460013092223996,"price_display":"25.46","price_state":"stated","total_value":3921809.4967,"total_display":"3,921,809.50","total_whole":"3,921,809","shares_owned_after":11339949.0,"shares_owned_after_display":"11,339,949","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-12","scope":"insider","n_lines":3},{"id":3228607,"accession":"0000950170-24-135796","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-135796","line_url":"/filing/0000950170-24-135796","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":308250.0,"shares_display":"308,250","price_per_share":25.365152660178428,"price_display":"25.37","price_state":"stated","total_value":7818808.3075,"total_display":"7,818,808.31","total_whole":"7,818,808","shares_owned_after":11519021.0,"shares_owned_after_display":"11,519,021","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-12","scope":"insider","n_lines":2},{"id":2073526,"accession":"0000950170-24-128607","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-128607","line_url":"/filing/0000950170-24-128607#line-2","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33273.0,"shares_display":"33,273","price_per_share":25.0786,"price_display":"25.08","price_state":"stated","total_value":834440.2578,"total_display":"834,440.26","total_whole":"834,440","shares_owned_after":11778760.0,"shares_owned_after_display":"11,778,760","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-19","scope":"insider"},{"id":2073523,"accession":"0000950170-24-128607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-128607","line_url":"/filing/0000950170-24-128607#line-1","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8530.0,"shares_display":"8,530","price_per_share":25.0218,"price_display":"25.02","price_state":"stated","total_value":213435.954,"total_display":"213,435.95","total_whole":"213,436","shares_owned_after":11812033.0,"shares_owned_after_display":"11,812,033","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-15","filed_date":"2024-11-19","scope":"insider"},{"id":3113104,"accession":"0000950170-24-127643","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-127643","line_url":"/filing/0000950170-24-127643#line-2","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9832.0,"shares_display":"9,832","price_per_share":25.0057,"price_display":"25.01","price_state":"stated","total_value":245856.0424,"total_display":"245,856.04","total_whole":"245,856","shares_owned_after":11820563.0,"shares_owned_after_display":"11,820,563","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-14","filed_date":"2024-11-15","scope":"insider"},{"id":3113100,"accession":"0000950170-24-127643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-127643","line_url":"/filing/0000950170-24-127643#line-1","is_derivative":false,"issuer_cik":"0001823747","issuer_name":"NewAmsterdam Pharma Co N.V.","issuer_ticker":"NAMS","issuer_name_source":null,"issuer_url":"/issuer/0001823747","owner_cik":null,"owner_name":"ForGrowth NAP B.V.; Forbion Capital Fund IV Cooperatief U.A.; Forbion Growth Management B.V.; Forbion Growth Opportunities Fund I Cooperatief U.A.; Forbion IV Management B.V.","owner_display_name":"ForGrowth NAP B.V.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1066.0,"shares_display":"1,066","price_per_share":25.0043,"price_display":"25.00","price_state":"stated","total_value":26654.5838,"total_display":"26,654.58","total_whole":"26,655","shares_owned_after":11830395.0,"shares_owned_after_display":"11,830,395","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-13","filed_date":"2024-11-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001936258","name":"NewAmsterdam Pharma Co N.V.","url":"/issuer/0001936258","role":"Ten percent owner","n_filings":9,"first_seen":"2024-11-15","last_seen":"2025-01-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002005384","retrieved_at":"2026-08-23T05:13:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}